<?xml version="1.0" encoding="UTF-8"?>
<ref id="B49">
 <label>49.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yamamoto</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Matsuyama</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Takeda</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Kawaguchi</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Inoue</surname>
    <given-names>JI</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Identification of nafamostat as a potent inhibitor of middle east respiratory syndrome coronavirus S protein-mediated membrane fusion using the split-protein-based cell-cell fusion assay</article-title>. 
  <source>Antimicrob Agents Chemother</source>. (
  <year>2016</year>) 
  <volume>60</volume>:
  <fpage>6532</fpage>â€“
  <lpage>9</lpage>. 
  <pub-id pub-id-type="doi">10.1128/AAC.01043-16</pub-id>
  <?supplied-pmid 27550352?>
  <pub-id pub-id-type="pmid">27550352</pub-id>
 </mixed-citation>
</ref>
